Results 1 to 10 of about 242,633 (111)

Associations between insulin-like growth factor binding protein-2 and lipoprotein kinetics in men [PDF]

open access: yesJournal of Lipid Research, 2022
Low circulating concentrations of insulin-like growth factor binding protein-2 (IGFBP-2) have been associated with dyslipidemia, notably with high triglyceride (TG) levels.
Chloé Rauzier   +4 more
doaj   +2 more sources

Recent Insights into Insulin-Like Growth Factor Binding Protein 2 Transcriptional Regulation [PDF]

open access: yesEndocrinology and Metabolism, 2017
Insulin-like growth factor binding proteins (IGFBPs) are major regulators of insulin-like growth factor bioavailability and activity in metabolic signaling. Seven IGFBP family isoforms have been identified.
Minsang Shin   +5 more
doaj   +2 more sources

Insulin-like growth factor binding protein 2: a core biomarker of left ventricular dysfunction in dilated cardiomyopathy [PDF]

open access: yesHereditas, 2023
Background RNA modifications, especially N6-methyladenosine, N1-methyladenosine and 5–methylcytosine, play an important role in the progression of cardiovascular disease.
Wei Yu   +9 more
doaj   +2 more sources

Serum Insulin-like Growth Factor-Binding Protein-2 as a Prognostic Factor for COVID-19 Severity [PDF]

open access: yesBiomedicines
Insulin-like growth factor-binding protein (IGFBP)-2 is a regulator of anabolic pathways, which become inactivated in severe illness. Here, we measured the serum IGFBP-2 levels of COVID-19 patients with moderate and severe disease as well as healthy ...
Patricia Mester   +9 more
doaj   +2 more sources

Insulin‐like growth factor binding protein‐2 and glucose‐regulated protein 78 kDa: Potential biomarkers affect prognosis in IDH‐wildtype glioblastoma patients [PDF]

open access: yesCancer Medicine, 2023
Background The overall survival of IDH‐wildtype glioblastoma patients is poor despite best available treatments. There is an urgent need for new biomarkers to inform more precise disease stratification.
Abigail J. Harland   +4 more
doaj   +2 more sources

Serum insulin‐like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma‐associated malnutrition and muscle wasting [PDF]

open access: yesJournal of Cachexia, Sarcopenia and Muscle, 2021
Background Malnutrition and muscle wasting are common features frequently observed in pancreatic ductal adenocarcinoma (PDAC) patients with cancer cachexia. They are associated with reduced survival and quality of life.
Jie Dong   +12 more
doaj   +2 more sources

Cardiovascular disease risk markers in children under 10 years of age and their relationship with serum concentrations of IGF-1, IGFBP-1, IGFBP-2 and IGFBP-3

open access: yesRevista de la Facultad de Medicina, 2020
Introduction: Any type of nutritional imbalance experienced during childhood will affect the health of an individual, both in their childhood and their adulthood.
Sorany Vera   +3 more
doaj   +1 more source

The Aberrant Expression of MicroRNA-125a-5p/IGF2BP3 Axis in Advanced Gastric Cancer and Its Clinical Relevance

open access: yesTechnology in Cancer Research & Treatment, 2020
RNA-binding proteins have been associated with cancer development. The overexpression of a well-known RNA-binding protein, insulin-like growth factor 2 messenger RNA–binding protein 3, has been identified as an indicator of poor prognosis in patients ...
Jing Zhang MS   +4 more
doaj   +1 more source

Insulin-like growth factor binding protein 1 DNA methylation in type 2 diabetes

open access: yesEgyptian Journal of Medical Human Genetics, 2021
Background Type 2 diabetes (T2D) is a complex trait in humans. Several environmental and hereditary factors contribute to the overall pathogenesis of this disease.
Sally M. Hafez   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy